Press Releases

ANN ARBOR – William R. Boudreaux, an attorney and shareholder in the Ann Arbor office of Brinks Hofer Gilson & Lione, one of the nation’s oldest intellectual property law firms, has been named co-chair of the firm’s Biotechnology and Pharmaceutical Practice Group. The Group counsels clients, from small start-ups and academic institutions to global corporations, on the ever-evolving body of law promoting and protecting biotechnology and pharmaceutical innovation in the United States and throughout the world.

Mr. Boudreaux has practiced as a patent attorney specializing in pharmaceuticals and chemicals since 1992. His practice includes client counseling for strategic patent portfolio development, global patent prosecution, IP diligence, and opinions for patentability, validity and freedom to operate.

Mr. Boudreaux’s experience includes over 15 years as in-house counsel in the pharmaceutical industry, including roles as patent counsel at Pfizer, Inc. and Eli Lilly and Co. Additionally, he was primary patent counsel for several late-stage and post-launch drug products, including four blockbuster drugs. Mr. Boudreaux also has extensive experience in global patent portfolio creation, legal opinions, product life-cycle planning and IP diligence. His experience also includes Hatch-Waxman litigation strategy and support, prosecution of patent reexamination and reissue applications, transactional work, appellate brief writing and international patent procurement and enforcement. Mr. Boudreaux represents a broad range of biotech and pharma clients ranging from large companies to start-ups.

Mr. Boudreaux holds a J.D. from the Louisiana State University Paul M. Hebert Law Center and a B.S. in Biochemistry from Louisiana State University.

Brinks Hofer Gilson & Lione is one of the largest intellectual property law firms in the United States and serves the intellectual property needs of clients around the world. Brinks has 150 attorneys, scientific advisors and patent agents who specialize in intellectual property litigation and all aspects of patent, trademark and copyright law. The firm also advises on issues relating to intellectual asset management, trade secret, unfair competition, and technology and licensing agreements. Brinks routinely handles assignments for companies in the electrical, chemical, and mechanical engineering sectors; the biotechnology, pharmaceutical and nanotechnology industries; and for companies whose work relates to Internet and computer technology law. The firm’s trademark practice works on behalf of clients who deal in a wide variety of products and services. Brinks is based in Chicago and has offices in Ann Arbor, Mich., Indianapolis, Ind., Research Triangle Park, N.C., Salt Lake City, Utah, and Washington, DC. More information is available at www.usebrinks.com.